Cargando…
BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing
(1) Background: Although, in the mutated BRCA detected in the Polish population of patients with breast cancer, there is a large percentage of recurrent pathogenic variants, an increasing need for the assessment of rare BRCA1/2 variants using NGS can be observed. (2) Methods: We studied 75 selected...
Autores principales: | Szczerba, Ewelina, Kamińska, Katarzyna, Mierzwa, Tomasz, Misiek, Marcin, Kowalewski, Janusz, Lewandowska, Marzena Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065856/ https://www.ncbi.nlm.nih.gov/pubmed/33918338 http://dx.doi.org/10.3390/genes12040519 |
Ejemplares similares
-
BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study
por: Kowalik, Artur, et al.
Publicado: (2018) -
Detection of somatic BRCA1/2 mutations in ovarian cancer – next‐generation sequencing analysis of 100 cases
por: Koczkowska, Magdalena, et al.
Publicado: (2016) -
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics
por: Śledzińska, Paulina, et al.
Publicado: (2022) -
Prognostic and Predictive Epigenetic Biomarkers in Oncology
por: Kamińska, Katarzyna, et al.
Publicado: (2018) -
Prevalence of the most frequent BRCA1 mutations in Polish population
por: Brozek, Izabela, et al.
Publicado: (2011)